Navigation Links
Valor Medical Announces First Human Implant of Neucrylate AN(TM) for Treatment of Cerebral Aneurysm
Date:3/20/2008

SAN DIEGO, March 20 /PRNewswire/ -- Valor Medical, an emerging medical device company in San Diego, CA, announced today that the first human implant of Neucrylate AN for treatment of cerebral aneurysms was performed by Dr. Sean Pakbaz at the University of Tehran. The treatment was under the guidance of a clinical protocol that had been approved by the University's Internal Ethics Committee.

Dr. Pakbaz stated that the patient's aneurysm was a type and location that is very difficult to treat. However, the insertion of the Neucrylate AN was very smooth and the total procedure time was significantly less than if the procedure had been done with a stent and coils. "The procedure went very well. The many practice implants I performed at Valor's simulated anatomical training lab prepared me for this trial. Valor's technology will make a major impact on how cerebral aneurysms are treated."

Valor Medical's Neucrylate AN is injected into the cerebral aneurysm through a micro-infusion catheter that is first inserted in the femoral artery. Neucrylate AN is a liquid that, when it comes in contact with blood, changes into a solid spongy material. The liquid enables the surgeon to totally fill the aneurysm regardless of shape, a property that is not found with implantable coils.

A cerebral aneurysm is a swelling of an artery in the brain. As the swelling increases the blood-vessel wall weakens and can rupture, causing bleeding and death. It is estimated that over 30,000 patients in the U.S. are diagnosed with cerebral aneurysms each year, and approximately 5 million individuals are walking around in the U.S. with undiagnosed cerebral aneurysms.


'/>"/>
SOURCE Valor Medical
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. NeoStem Reports Positive Stem Cell Industry Research Trends From The Journal of the American Medical Association and Third Annual Stem Cell Summit
2. ATS Medical Announces Initial Clinical Results of Stand-Alone Atrial Fibrillation Procedures Using ATS CryoMaze Product Line
3. Data Demonstrate that Obagi Medical Products Condition & Enhance Skin Care System is an Effective Complement to Facial Rejuvenation Procedures
4. Berkery Noyes Represented The Thomson Corporation in the Sale of CenterWatch and New England Institutional Review Board to Jobson Medical Information
5. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
6. Physicians Will Benefit from Medical Software Advice Website
7. Siemens Medical Solutions Diagnostics Inks Agreement with KreLo Medical Diagnostics to Expand Thyroid Immunoassay Menu
8. Vanderbilt Medical Center Seeks Middle Tennesseans with Type 2 Diabetes Who are Overweight for National Clinical Trial
9. Concentra Medical Centers Gears Up for Flu Season to Keep Area Workforce Healthy
10. Lack of Medicare Part D Coverage for All Medically Necessary Prescriptions Endangers Older Americans and Those with Chronic Diseases and Disabilities
11. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... 12, 2017   Divoti USA will engrave ... the standard of the latest FDA requirements, which stipulates new criteria ... Anyone in need of Medical ID jewelry such as Medical ID ... are engraved in terms of the new FDA requirements . ... Divoti offers this dark mark ...
(Date:10/11/2017)... 2017  True Health, a leader in integrated ... during National Breast Cancer Awareness month to educate ... Research recently published ... more than 10 million American women are at ... or BRCA2 and have not had testing. These mutations ...
(Date:10/7/2017)... Oct. 6, 2017   Provista, a proven ... $100 billion in purchasing power, today announced a new ... The Newsroom is the online home for ... infographics, expert bios, news releases, slideshows and events. ... a wealth of resources at their fingertips, viewers can ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in ... 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced ... 2017. , The annual award competition recognizes editorial and design excellence across a range ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health ... Miles by Moonlight to raise money for the American Heart Association Heart Walk. Teams ... Teams will work together to keep their treadmills moving for 5 hours. Treadmills will ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), ... patient education, today announce a new strategic alliance. , As CPEN’s strategic ...
(Date:10/12/2017)... Miramar, FL (PRWEB) , ... October 12, 2017 ... ... is presenting the latest in wound care advancements to physician colleagues, skilled nursing ... lecture is titled, "Navigating the Treacherous Waters of Wound Care." , "At many ...
Breaking Medicine News(10 mins):